Concurrent Chemo-Radiation in Muscle Invasive Bladder Cancer

The New Immuno-Oncology Era in Early-Stage Bladder CancerПодробнее

Bladder Sparing Regimens for Muscle Invasive Disease: Should We Be Doing this More?Подробнее

LO based - March 2023: Muscle invasive Bladder cancer by Dr. Sadia Sadiq and Dr. Nadeem PervezПодробнее

Beyond bladder preservation: Radiotherapy across the spectrum of bladder cancer treatment | BCAN TTПодробнее

Trimodality Therapy for Management of Muscle Invasive Bladder Cancer (2021)Подробнее

Pembro + Gem & concurrent hypofractionated RT as bladder sparing treatment for MIBCПодробнее

Bladder-Sparing Trimodality TherapyПодробнее

A Review of AUA/SUO/ASTRO Guidelines for Muscle Invasive Bladder Cancer (MIBC)Подробнее

Bladder Sparing Tri-Modal Therapy UpdatesПодробнее

Definitive Radiation-Based Therapy for Muscle Invasive Bladder CancerПодробнее

Integration of radiotherapy in muscle-invasive bladder cancerПодробнее

Trimodality Therapy for Management of Muscle Invasive Bladder CancerПодробнее

Bladder preservation strategies for MIBC - EMPIRE Urology Lecture SeriesПодробнее

IVU VVP: Muscle Invasive Bladder Cancer with Dr. Phillip AbboshПодробнее

Urology 60 Minutes - Episode 7 -“MIBC management during COVID19 pandemic”Подробнее

Genomic profiling of muscle invasive bladder cancerПодробнее

Highlighting Clinical Trials: Muscle Invasive Bladder Cancer | Part II: Current MIBC Clinical TrialsПодробнее

Evidence and Insights on Innovative Treatment for Bladder CancerПодробнее

INTACT: safety results of CRT with and without atezolizumab in MIBCПодробнее